{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:06:33Z","timestamp":1790258793835,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"DOI":"10.1007\/s42000-026-00824-w","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:45:49Z","timestamp":1790257549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipodystrophies and female reproduction: pathophysiology, clinical spectrum, and management across the reproductive lifespan"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4185-8710","authenticated-orcid":false,"given":"Dimitrios","family":"Pappas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifigenia","family":"Kostoglou-Athanassiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Troupis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"824_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","volume":"108","author":"A Garg","year":"2000","unstructured":"Garg A (2000) Lipodystrophies. Am J Med 108:143\u201352. https:\/\/doi.org\/10.1016\/S0002-9343(99)00414-3","journal-title":"Am J Med"},{"key":"824_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2015.123","volume":"11","author":"N Patni","year":"2015","unstructured":"Patni N, Garg A (2015) Congenital generalized lipodystrophies\u2014new insights into metabolic dysfunction. Nat Rev Endocrinol 11:522\u201334. https:\/\/doi.org\/10.1038\/nrendo.2015.123","journal-title":"Nat Rev Endocrinol"},{"key":"824_CR3","doi-asserted-by":"publisher","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, et al (2016) The diagnosis and management of lipodystrophy syndromes. J Clin Endocrinol Metab. 101:4500\u201311. https:\/\/doi.org\/10.1210\/jc.2016-2466","DOI":"10.1210\/jc.2016-2466"},{"key":"824_CR4","doi-asserted-by":"publisher","unstructured":"Hegele RA, Joy TR, Al-Attar SA, Rutt BK (2007) Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res. 48:1433\u201344. https:\/\/doi.org\/10.1194\/jlr.R700004-JLR200","DOI":"10.1194\/jlr.R700004-JLR200"},{"key":"824_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa040388","volume":"351","author":"CK Welt","year":"2004","unstructured":"Welt CK, Chan JL, Bullen J, Murphy R, Smith P, DePaoli AM et al (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351:987\u201397. https:\/\/doi.org\/10.1056\/NEJMoa040388","journal-title":"N Engl J Med"},{"key":"824_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1023\/A:1012947113197","volume":"4","author":"JL Chan","year":"2001","unstructured":"Chan JL, Mantzoros CS (2001) Leptin and the hypothalamic\u2013pituitary regulation of the gonadotropin-gonadal axis. Pituitary 4:87\u201392. https:\/\/doi.org\/10.1023\/A:1012947113197","journal-title":"Pituitary"},{"key":"824_CR7","doi-asserted-by":"publisher","unstructured":"Yu WH, Kimura M, Walczewska A, Karanth S, McCann SM (1997) Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci U S A. 94:1023\u20138. https:\/\/doi.org\/10.1073\/pnas.94.3.1023","DOI":"10.1073\/pnas.94.3.1023"},{"key":"824_CR8","doi-asserted-by":"publisher","unstructured":"Childs GV, Odle AK, MacNicol MC, MacNicol AM (2021) The importance of leptin to reproduction. Endocrinology. 162: bqaa204. https:\/\/doi.org\/10.1210\/endocr\/bqaa204","DOI":"10.1210\/endocr\/bqaa204"},{"key":"824_CR9","doi-asserted-by":"publisher","unstructured":"Mantzoros C, Flier JS, Lesem MD, Brewerton TD, Jimerson DC (1997) Cerebrospinal fluid leptin in anorexia nervosa. J Clin Endocrinol Metab. 82:1845\u201351. https:\/\/doi.org\/10.1210\/jcem.82.6.4006","DOI":"10.1210\/jcem.82.6.4006"},{"key":"824_CR10","doi-asserted-by":"publisher","unstructured":"Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 110:1093\u2013103. https:\/\/doi.org\/10.1172\/JCI15693","DOI":"10.1172\/JCI15693"},{"key":"824_CR11","doi-asserted-by":"publisher","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited. Endocr Rev. 33:981\u20131030. https:\/\/doi.org\/10.1210\/er.2011-1034","DOI":"10.1210\/er.2011-1034"},{"key":"824_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJM199608293350902","volume":"335","author":"JE Nestler","year":"1996","unstructured":"Nestler JE, Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17\u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617\u201323. https:\/\/doi.org\/10.1056\/NEJM199608293350902","journal-title":"N Engl J Med"},{"key":"824_CR13","doi-asserted-by":"publisher","unstructured":"Pasquali R, Gambineri A (2013) Insulin sensitizers in polycystic ovary syndrome. Front Horm Res. 40:83\u2013102. https:\/\/doi.org\/10.1159\/000341837","DOI":"10.1159\/000341837"},{"key":"824_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R (2002) Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883\u201396. https:\/\/doi.org\/10.1038\/sj.ijo.0801994","journal-title":"Int J Obes Relat Metab Disord"},{"key":"824_CR15","doi-asserted-by":"publisher","unstructured":"Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med. 346:570\u20138. https:\/\/doi.org\/10.1056\/NEJMoa012437","DOI":"10.1056\/NEJMoa012437"},{"key":"824_CR16","doi-asserted-by":"publisher","unstructured":"Oral EA, Gorden P, Cochran E, Ara\u00fajo-Vilar D, Savage DB, Long A, et al (2019) Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy. Endocrine. 64:500\u201311. https:\/\/doi.org\/10.1007\/s12020-019-01862-8","DOI":"10.1007\/s12020-019-01862-8"},{"key":"824_CR17","doi-asserted-by":"publisher","unstructured":"Clarkson J, d\u2019Anglemont de Tassigny X, Moreno AS, Colledge WH, Herbison AE (2008) Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation. J Neurosci. 28:8691\u20137. https:\/\/doi.org\/10.1523\/JNEUROSCI.1775-08.2008","DOI":"10.1523\/JNEUROSCI.1775-08.2008"},{"key":"824_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41574-020-0363-7","volume":"16","author":"VM Navarro","year":"2020","unstructured":"Navarro VM (2020) Metabolic regulation of kisspeptin\u2014the link between energy balance and reproduction. Nat Rev Endocrinol 16:407\u201320. https:\/\/doi.org\/10.1038\/s41574-020-0363-7","journal-title":"Nat Rev Endocrinol"},{"key":"824_CR19","doi-asserted-by":"publisher","unstructured":"Brann DW, Wade MF, Dhandapani KM, Mahesh VB, Buchanan CD (2002) Leptin and reproduction. Steroids. 67:95\u2013104. https:\/\/doi.org\/10.1016\/S0039-128X(01)00138-6","DOI":"10.1016\/S0039-128X(01)00138-6"},{"key":"824_CR20","doi-asserted-by":"publisher","unstructured":"Fisher FM, Maratos-Flier E (2016) Understanding the physiology of FGF21. Annu Rev Physiol. 78:223\u201341. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105339","DOI":"10.1146\/annurev-physiol-021115-105339"},{"key":"824_CR21","doi-asserted-by":"publisher","unstructured":"Spranger J, Kroke A, M\u00f6hlig M, Bergmann MM, Ristow M, Boeing H, et al (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet. 361:226\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(03)12255-6","DOI":"10.1016\/S0140-6736(03)12255-6"},{"key":"824_CR22","doi-asserted-by":"publisher","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, et al (2014) Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014:719050. https:\/\/doi.org\/10.1155\/2014\/719050","DOI":"10.1155\/2014\/719050"},{"key":"824_CR23","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M et al (2016) The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline. J Clin Endocrinol Metab 101:4500\u201311. https:\/\/doi.org\/10.1210\/jc.2016-2466","journal-title":"J Clin Endocrinol Metab"},{"key":"824_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.med.57.022605.114424","volume":"57","author":"AK Agarwal","year":"2016","unstructured":"Agarwal AK, Garg A (2016) Genetic basis of lipodystrophies and management of metabolic complications. Annu Rev Med 57:297\u2013311. https:\/\/doi.org\/10.1146\/annurev.med.57.022605.114424","journal-title":"Annu Rev Med"},{"key":"824_CR25","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1210\/jc.2016-3628","volume":"102","author":"RJ Brown","year":"2017","unstructured":"Brown RJ, Meehan CA, Cochran E, Rother KI, Kleiner DE, Walter M et al (2017) Effects of metreleptin in pediatric patients with lipodystrophy. J Clin Endocrinol Metab 102:1511\u20139. https:\/\/doi.org\/10.1210\/jc.2016-3628","journal-title":"J Clin Endocrinol Metab"},{"key":"824_CR26","doi-asserted-by":"publisher","unstructured":"Ren M, Shi J, Jia J, Guo Y, Ni X, Shi T (2002) Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet. 39:722\u201333. https:\/\/doi.org\/10.1136\/jmg.39.10.722","DOI":"10.1136\/jmg.39.10.722"},{"key":"824_CR27","doi-asserted-by":"publisher","unstructured":"Garg A, Vinaitheerthan M, Weatherall PT, Bowcock AM (2001) Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a\/c gene. J Clin Endocrinol Metab.86:59\u201365. https:\/\/doi.org\/10.1210\/jcem.86.1.7121","DOI":"10.1210\/jcem.86.1.7121"},{"key":"824_CR28","doi-asserted-by":"publisher","unstructured":"Hegele RA (2004) Familial partial lipodystrophy. Semin Vasc Med. 4:147\u201353. https:\/\/doi.org\/10.1055\/s-2004-835063","DOI":"10.1055\/s-2004-835063"},{"key":"824_CR29","doi-asserted-by":"publisher","unstructured":"Ajluni N, Meral R, Neidert AH, Brady GF, Buras E, McKenna B, et al (2017) Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort. Clin Endocrinol (Oxf). 86:698\u2013707. https:\/\/doi.org\/10.1111\/cen.13311","DOI":"10.1111\/cen.13311"},{"key":"824_CR30","doi-asserted-by":"publisher","unstructured":"Mosbah H, Donadille B, Vatier C, Janmaat S, Atlan M, Badens C, et al (2022) Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS). Orphanet J Rare Dis. 17:170. https:\/\/doi.org\/10.1186\/s13023-022-02308-7","DOI":"10.1186\/s13023-022-02308-7"},{"key":"824_CR31","doi-asserted-by":"publisher","unstructured":"Misra A, Peethambaram A, Garg A (2004) Clinical features and metabolic derangements in acquired generalized lipodystrophy. Medicine (Baltimore). 83:18\u201334. https:\/\/doi.org\/10.1097\/00005792-200303000-00007","DOI":"10.1097\/00005792-200303000-00007"},{"key":"824_CR32","doi-asserted-by":"publisher","unstructured":"Hegele RA, Cao H, Liu DM, Costain GA, Charlton-Menys V, Rodger NW, et al (2006) Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy. Am J Hum Genet. 79:383\u20139. https:\/\/doi.org\/10.1086\/505885","DOI":"10.1086\/505885"},{"key":"824_CR33","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1210\/jc.2015-2589","volume":"100","author":"J Lebastchi","year":"2015","unstructured":"Lebastchi J, Ajluni N, Neidert A, Oral EA (2015) A report of three cases with acquired generalized lipodystrophy with distinct autoimmune conditions treated with metreleptin. J Clin Endocrinol Metab 100:3967\u201370. https:\/\/doi.org\/10.1210\/jc.2015-2589","journal-title":"J Clin Endocrinol Metab"},{"key":"824_CR34","doi-asserted-by":"publisher","unstructured":"Santoro N, Brown JR, Adel T, Skurnick JH (1996) Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab. 81:1495\u2013501. https:\/\/doi.org\/10.1210\/jcem.81.4.8636357","DOI":"10.1210\/jcem.81.4.8636357"},{"key":"824_CR35","doi-asserted-by":"publisher","unstructured":"Brown RJ, Oral EA (2017) Emerging therapies for lipodystrophy. Nat Rev Endocrinol. 13:241\u201355. https:\/\/doi.org\/10.1038\/nrendo.2016.216","DOI":"10.1038\/nrendo.2016.216"},{"key":"824_CR36","doi-asserted-by":"publisher","unstructured":"Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Pathogenesis of HIV-1 protease inhibitor-associated lipodystrophy. Lancet. 351:1881\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(98)03391-1","DOI":"10.1016\/S0140-6736(98)03391-1"},{"key":"824_CR37","doi-asserted-by":"publisher","unstructured":"Chen D, Misra A, Garg A (2002) Lipodystrophy in HIV-infected patients. J Clin Endocrinol Metab. 87:4845\u201356. https:\/\/doi.org\/10.1210\/jcem.87.11.8931","DOI":"10.1210\/jcem.87.11.8931"},{"key":"824_CR38","doi-asserted-by":"publisher","unstructured":"Sinha U, Sengupta N, Mukhopadhyay P, Roy KS (2005) Absence of polycystic ovary syndrome features in HIV-infected women. J Clin Endocrinol Metab. 90:5596\u2013604. https:\/\/doi.org\/10.1210\/jc.2005-1083","DOI":"10.1210\/jc.2005-1083"},{"key":"824_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/jwh.2021.0276","volume":"31","author":"SB Coburn","year":"2022","unstructured":"Coburn SB, Dionne-Odom J, Alcaide ML, Moran CA, Rahangdale L, Golub ET et al (2022) The association between HIV status, estradiol, and sex hormone binding globulin among premenopausal women in the Women\u2019s Interagency HIV Study. J Womens Health (Larchmt) 31:183\u2013193. https:\/\/doi.org\/10.1089\/jwh.2021.0276","journal-title":"J Womens Health (Larchmt)"},{"key":"824_CR40","doi-asserted-by":"publisher","unstructured":"Van Ommen CE, Hsieh AYY, Albert AY, Kimmel ER, Cote HCF, Maan EJ, et al (2023) Lower anti-M\u00fcllerian hormone levels in women living with HIV. AIDS. 37:769\u201378. https:\/\/doi.org\/10.1097\/QAD.0000000000003481","DOI":"10.1097\/QAD.0000000000003481"},{"key":"824_CR41","doi-asserted-by":"publisher","unstructured":"King EM, Swann SA, Murray MCM (2023) Markers of ovarian reserve in women living with HIV: a systematic review. HIV Med. 24:247\u201359. https:\/\/doi.org\/10.1111\/hiv.13364","DOI":"10.1111\/hiv.13364"},{"key":"824_CR42","doi-asserted-by":"publisher","unstructured":"Powis KM, Kitch D, Ogwu A, Hughes MD, Lockman S, Leidner J, et al (2011) Increased risk of preterm delivery among HIV-infected women randomized to protease inhibitor-based therapy during pregnancy. J Infect Dis. 204:506\u201314. https:\/\/doi.org\/10.1093\/infdis\/jir307","DOI":"10.1093\/infdis\/jir307"},{"key":"824_CR43","doi-asserted-by":"publisher","unstructured":"Dunk CE, Serghides L (2022) Protease inhibitor therapy in pregnancy: placental and endocrine effects. Lancet HIV. 9: e120\u20139. https:\/\/doi.org\/10.1016\/S2352-3018(21)00249-6","DOI":"10.1016\/S2352-3018(21)00249-6"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-026-00824-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-026-00824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:45:49Z","timestamp":1790257549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-026-00824-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":43,"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1007\/s42000-026-00824-w","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}